Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2022 2023 2024 2025 2026 2027
Market Cap 1 895.3 332.2 180.9 57.55 66.59 66.59 -
Change - - -45.55% -68.19% 15.71% 0% -
Enterprise Value (EV) 895.3 332.2 180.9 57.55 66.59 66.59 66.59
Change - - -45.55% -68.19% 15.71% 0% 0%
P/E - -24.4x -17.8x -5.88x - - -
PBR - - - - - - -
PEG - - 0.6x 0.2x - - -
Capitalization / Revenue 566x - 187x 53.7x 95.4x 55.5x 51.2x
EV / Revenue 0x - 0x 0x 60.5x 55.5x 51.2x
EV / EBITDA - - - - - - -
EV / EBIT - - -0x -0x -11.1x -10.2x -10.4x
EV / FCF - - -0x - -11.1x -10.4x -18.5x
FCF Yield - - -9.52% - -4.08% -9.61% -5.41%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 - -0.29 -0.2 -0.15 - - -
Distribution rate - - - - - - -
Net sales 1 1.583 - 0.97 1.072 1.174 1.2 1.3
EBITDA - - -11.16 -5.416 - - -
EBIT 1 - - -13.43 -6.083 0.639 -6.5 -6.4
Net income - -13.62 -10.05 -7.831 - - -
Net Debt - - - - - - -
Reference price 2 19.6600 7.0900 3.5550 0.8820 0.8700 0.8700 0.8700
Nbr of stocks (in thousands) 45,540 46,861 50,891 65,248 76,539 76,539 -
Announcement Date 30/04/21 01/03/23 15/05/24 13/05/25 13/05/26 - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
50.8x4.75x19.31x2.94% 28TCr
22.45x3.1x11.03x1.75% 6.63TCr
16.49x2.08x7.14x2.71% 823.69Cr
10.18x5.26x8.1x - 813.09Cr
21.9x6.55x17.91x-.--% 445.07Cr
42.25x2.39x29.15x0.73% 370.76Cr
29.4x5.61x16.05x - 341.75Cr
102.42x - - -.--% 257.58Cr
Average 36.99x 4.25x 15.53x 1.35% 4.73TCr
Weighted average by Cap. 43.94x 4.42x 17.39x 2.64%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!